AAAAAA

   
Results: 1-22 |
Results: 22
Autonomic regulation of neuroimmunological responses: Implications for multiple sclerosis
Authors: Frohman, EM Monson, NL Lovett-Racke, AE Racke, MK
Citation: Em. Frohman et al., Autonomic regulation of neuroimmunological responses: Implications for multiple sclerosis, J CLIN IMM, 21(2), 2001, pp. 61-73
MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis
Authors: Frohman, EM Zhang, H Kramer, PD Fleckenstein, J Hawker, K Racke, MK Frohman, TC
Citation: Em. Frohman et al., MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis, NEUROLOGY, 57(5), 2001, pp. 762-768
Ocular contrapulsion in multiple sclerosis: clinical features and pathophysiological mechanisms
Authors: Frohman, EM Frohman, TC Fleckenstein, J Racke, MK Hawker, K Kramer, PD
Citation: Em. Frohman et al., Ocular contrapulsion in multiple sclerosis: clinical features and pathophysiological mechanisms, J NE NE PSY, 70(5), 2001, pp. 688-692
T cell epitopes of human myelin oligodendrocyte glycoprotein identified inHLA-DR4 (DRBI0401) transgenic mice are encephalitogenic and are presentedby human B cells
Authors: Forsthuber, TG Shive, CL Wienhold, W de Graaft, K Spack, EG Sublett, R Melms, A Kort, J Racke, MK Weissert, R
Citation: Tg. Forsthuber et al., T cell epitopes of human myelin oligodendrocyte glycoprotein identified inHLA-DR4 (DRBI0401) transgenic mice are encephalitogenic and are presentedby human B cells, J IMMUNOL, 167(12), 2001, pp. 7119-7125
Role of nerve growth factor in experimental autoimmune encephalomyelitis
Authors: Arredondo, LR Deng, CS Ratts, RB Lovett-Racke, AE Holtzman, DM Racke, MK
Citation: Lr. Arredondo et al., Role of nerve growth factor in experimental autoimmune encephalomyelitis, EUR J IMMUN, 31(2), 2001, pp. 625-633
Multiple sclerosis and magnetic resonance imaging - Advancement in linkingthe pictures with the progression
Authors: Racke, MK
Citation: Mk. Racke, Multiple sclerosis and magnetic resonance imaging - Advancement in linkingthe pictures with the progression, ARCH NEUROL, 58(1), 2001, pp. 35-36
The role of costimulation in autoimmune demyelination
Authors: Racke, MK Ratts, RB Arredondo, L Perrin, PJ Lovett-Racke, A
Citation: Mk. Racke et al., The role of costimulation in autoimmune demyelination, J NEUROIMM, 107(2), 2000, pp. 205-215
Retrovirus mediated gene transfer of the self antigen MBP into the bone marrow of mice alters resistance to experimental autoimmune encephalomyelitis
Authors: Peters, TR Bodine, DM McDonagh, KT Lovett-Racke, A McFarland, HF McFarlin, DE Nienhuis, AW Racke, MK
Citation: Tr. Peters et al., Retrovirus mediated gene transfer of the self antigen MBP into the bone marrow of mice alters resistance to experimental autoimmune encephalomyelitis, J NEUROIMM, 103(1), 2000, pp. 51-62
Vertigo in MS: Utility of positional and particle repositioning maneuvers
Authors: Frohman, EM Zhang, H Dewey, RB Hawker, KS Racke, MK Frohman, TC
Citation: Em. Frohman et al., Vertigo in MS: Utility of positional and particle repositioning maneuvers, NEUROLOGY, 55(10), 2000, pp. 1566-1568
Developmentally regulated gene expression of Th2 cytokines in the brain
Authors: Lovett-Racke, AE Smith, ME Arredondo, LR Bittner, PS Ratts, RB Shive, CL Forsthuber, TG Racke, MK
Citation: Ae. Lovett-racke et al., Developmentally regulated gene expression of Th2 cytokines in the brain, BRAIN RES, 870(1-2), 2000, pp. 27-35
The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: i.p. antigen administration
Authors: Ratts, RB Arredondo, LR Bittner, P Perrin, PJ Lovett-Racke, AE Racke, MK
Citation: Rb. Ratts et al., The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: i.p. antigen administration, INT IMMUNOL, 11(12), 1999, pp. 1881-1888
The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: i.v. antigen administration
Authors: Ratts, RB Arredondo, LR Bittner, P Perrin, PJ Lovett-Racke, AE Racke, MK
Citation: Rb. Ratts et al., The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: i.v. antigen administration, INT IMMUNOL, 11(12), 1999, pp. 1889-1895
Differential requirements of naive and memory T cells for CD28 costimulation in autoimmune pathogenesis
Authors: Perrin, PJ Lovett-Racke, A Phillips, SM Racke, MK
Citation: Pj. Perrin et al., Differential requirements of naive and memory T cells for CD28 costimulation in autoimmune pathogenesis, HIST HISTOP, 14(4), 1999, pp. 1269-1276
Blockade of CD28 during in vitro activation of encephalitogenic T cells orafter disease onset ameliorates experimental autoimmune encephalomyelitis
Authors: Perrin, PJ June, CH Maldonado, JH Ratts, RB Racke, MK
Citation: Pj. Perrin et al., Blockade of CD28 during in vitro activation of encephalitogenic T cells orafter disease onset ameliorates experimental autoimmune encephalomyelitis, J IMMUNOL, 163(3), 1999, pp. 1704-1710
T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis
Authors: Cross, AH Lyons, JA San, M Keeling, RM Ku, G Racke, MK
Citation: Ah. Cross et al., T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis, EUR J IMMUN, 29(10), 1999, pp. 3140-3147
Age dependence of clinical and pathological manifestations of autoimmune demyelination - Implications for multiple sclerosis
Authors: Smith, ME Eller, NL McFarland, HF Racke, MK Raine, CS
Citation: Me. Smith et al., Age dependence of clinical and pathological manifestations of autoimmune demyelination - Implications for multiple sclerosis, AM J PATH, 155(4), 1999, pp. 1147-1161
Bystander suppression in experimental autoimmune encephalomyelitis: where and how does it occur?
Authors: Racke, MK Lovett-Racke, AE
Citation: Mk. Racke et Ae. Lovett-racke, Bystander suppression in experimental autoimmune encephalomyelitis: where and how does it occur?, RES IMMUNOL, 149(9), 1998, pp. 820-827
Antigen-driven regulation of experimental autoimmune encephalomyelitis - Discussion
Authors: Begolka, WS Miller, SD Segal, BM Racke, MK Lovett-Racke, AE
Citation: Ws. Begolka et al., Antigen-driven regulation of experimental autoimmune encephalomyelitis - Discussion, RES IMMUNOL, 149(9), 1998, pp. 842-843
Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental encephalomyelitis - Discussion
Authors: Willenborg, DO Racke, MK Lovett-Racke, AE Hoffman, LM Karpus, WJ Owens, T
Citation: Do. Willenborg et al., Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental encephalomyelitis - Discussion, RES IMMUNOL, 149(9), 1998, pp. 843-844
Immune cell entry to the CNS - a focus for immunoregulation of EAE - Discussion
Authors: Segal, BM Willenborg, DO Racke, MK Lovett-Racke, AE Hoffman, LM Karpus, WJ Begolka, WS Miller, SD
Citation: Bm. Segal et al., Immune cell entry to the CNS - a focus for immunoregulation of EAE - Discussion, RES IMMUNOL, 149(9), 1998, pp. 844-846
Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease? Discussion
Authors: Owens, T Segal, BM Racke, MK Lovett-Racke, AE Begolka, WS Miller, SD
Citation: T. Owens et al., Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease? Discussion, RES IMMUNOL, 149(9), 1998, pp. 849-850
The comeback of the elusive "suppressor" cell: an update on the regulatorynetwork in EAE - Discussion
Authors: Begolka, WS Miller, SD Hoffman, LM Karpus, WJ Owens, T Racke, MK
Citation: Ws. Begolka et al., The comeback of the elusive "suppressor" cell: an update on the regulatorynetwork in EAE - Discussion, RES IMMUNOL, 149(9), 1998, pp. 850-851
Risultati: 1-22 |